Phosphorus (Serum Inorganic Phosphate) Test
Serum phosphorus measures inorganic phosphate, the extracellular fraction of the body's principal intracellular anion, regulated by fibroblast growth factor 23, parathyroid hormone, and calcitriol. It is used to detect hypophosphataemia and hyperphosphataemia, monitor chronic kidney disease, and anticipate refeeding syndrome.
1
Biomarkers
Blood (serum)
Sample
1–2 business days
Turnaround
Yes — a fasting morning sample is preferred, since recent phosphate-rich meals raise levels and phosphorus follows a diurnal rhythm with a morning nadir
Fasting
What is the Phosphorus test?
The Phosphorus Test measures serum inorganic phosphate, the extracellular fraction of the body's principal intracellular anion. Phosphate is essential to ATP, nucleic acids, cell membranes, and bone mineralisation, and its serum concentration is regulated by fibroblast growth factor 23, parathyroid hormone, and calcitriol acting on the kidney and intestine. It is ordered to detect hypophosphataemia and hyperphosphataemia, to assess bone and mineral disorders alongside calcium and parathyroid hormone, to monitor chronic kidney disease, and to anticipate refeeding syndrome in nutritionally at-risk patients. Within mineral assessment, serum phosphorus is validated and routine but must be read with a clear understanding of what it can and cannot show. Because under 1% of body phosphate is extracellular, the serum value is a poor surrogate for total body stores, and it moves acutely with transcellular shifts — insulin and glucose administration, respiratory alkalosis, and catecholamine surges all drive phosphate into cells and lower serum levels without any change in total body content. A normal result therefore does not exclude meaningful depletion, particularly in malnourished, alcohol-dependent, or critically unwell patients. The reverse also applies: haemolysis and delayed serum separation release intracellular phosphate and falsely elevate results, so pre-analytical handling matters. Phosphorus is most informative as part of a mineral panel with calcium, parathyroid hormone, 25-hydroxyvitamin D, magnesium, and renal function, where the pattern across markers localises the problem — and in refeeding risk, where the clinically important signal is a falling trend during nutritional replenishment rather than any single value.
What does the Phosphorus test measure?
Phosphate is the principal intracellular anion and an essential constituent of ATP, nucleic acids, phospholipid membranes, and 2,3-diphosphoglycerate. Approximately 85% of body phosphate resides in bone as hydroxyapatite and most of the remainder is intracellular, leaving under 1% in the extracellular compartment that serum measurement samples. Homeostasis is governed by fibroblast growth factor 23, parathyroid hormone, and calcitriol acting on renal proximal tubular reabsorption and intestinal absorption. Serum levels follow a diurnal rhythm, with a nadir in the morning and a rise through the afternoon and evening.
Serum phosphorus is a validated and routine measure used to detect hypophosphataemia and hyperphosphataemia, to monitor chronic kidney disease and mineral bone disorder, and to anticipate and manage refeeding syndrome. Its principal limitation is that it samples only the small extracellular fraction and therefore reflects total body phosphate stores poorly: levels shift acutely with transcellular movement driven by insulin, glucose, and pH, so a normal serum phosphorus does not exclude significant total body depletion. It is interpreted alongside calcium, parathyroid hormone, vitamin D, magnesium, and renal function rather than in isolation.
Why is the Phosphorus test ordered?
- Monitoring of chronic kidney disease and chronic kidney disease–mineral and bone disorder, where phosphate retention is an established complication
- Assessment of patients at risk of refeeding syndrome — prolonged undernutrition, anorexia nervosa, alcohol dependence, or bariatric surgery — with serial measurement during nutritional replenishment
- Investigation of bone and mineral disorders alongside calcium, parathyroid hormone, and 25-hydroxyvitamin D, including suspected hyperparathyroidism or osteomalacia
- Evaluation of unexplained muscle weakness, rhabdomyolysis, respiratory muscle failure, or altered mental state where hypophosphataemia is in the differential
- Assessment of patients on prolonged parenteral nutrition, diuretics, phosphate binders, or antacids affecting phosphate handling
- Investigation of suspected inherited or acquired renal phosphate wasting, including X-linked hypophosphataemia and tumour-induced osteomalacia, alongside FGF23 where available
- Assessment in diabetic ketoacidosis and its treatment, where insulin-driven transcellular shift can produce marked hypophosphataemia during correction
Sample collection and turnaround
Sample type
Blood (serum)
Fasting required
Yes — a fasting morning sample is preferred, since recent phosphate-rich meals raise levels and phosphorus follows a diurnal rhythm with a morning nadir
Collection method
Venipuncture at patient service centre
Turnaround
1–2 business days
Collection notes
Collect a fasting morning sample where possible and keep collection timing consistent for serial monitoring. Avoid haemolysis and separate serum from cells promptly, since delayed separation falsely elevates results. Document renal function, phosphate binders, antacids, diuretics, vitamin D analogues, parenteral nutrition, and refeeding status. In patients at refeeding risk, interpret trend rather than a single value.
Specimen requirements
Minimum 0.5 mL serum. Separate serum from cells promptly per Access Medical Laboratories protocol to avoid falsely elevated results. Avoid haemolysis. Specimen stable refrigerated; follow Access Medical Laboratories transport guidelines.
What can affect Phosphorus results?
Phosphate is predominantly intracellular, so red cell lysis or prolonged contact between serum and cells releases phosphate into the sample and falsely elevates results. Prompt separation and avoidance of haemolysis are essential.
Insulin drives phosphate into cells alongside glucose and potassium, producing an acute fall in serum phosphorus without a change in total body stores. This is the mechanism underlying refeeding syndrome and the fall seen during treatment of diabetic ketoacidosis.
Intracellular alkalosis stimulates glycolysis and phosphorylation of glycolytic intermediates, consuming phosphate and shifting it into cells. This can produce marked hypophosphataemia in hyperventilating or critically ill patients, again without true depletion.
Serum phosphorus follows a diurnal rhythm with a morning nadir and afternoon rise, and a phosphate-rich meal transiently raises levels. A fasting morning sample and consistent collection timing improve comparability of serial results.
Phosphate binders and aluminium- or magnesium-containing antacids reduce intestinal absorption and lower phosphorus, while vitamin D analogues increase absorption and raise it; thiazides, acetazolamide, and bisphosphonates alter renal handling. Medication history should be documented.
Phosphate is excreted renally, so declining glomerular filtration causes retention and progressive hyperphosphataemia, which becomes a central feature of chronic kidney disease–mineral and bone disorder in advanced disease.
What do Phosphorus results mean?
Elevated
Hyperphosphataemia most commonly reflects reduced renal excretion in chronic or acute kidney disease. Other causes include hypoparathyroidism, vitamin D excess, tumour lysis syndrome, rhabdomyolysis, and acidosis-driven transcellular shift, alongside spurious elevation from haemolysis or delayed serum separation. Marked elevation with hypocalcaemia raises concern for tumour lysis or rhabdomyolysis and warrants urgent assessment; sustained elevation in chronic kidney disease drives secondary hyperparathyroidism and vascular calcification.
Normal
A normal serum phosphorus is reassuring but does not exclude significant total body phosphate depletion, since under 1% of body phosphate is extracellular. In patients at refeeding risk, a normal baseline value is expected and the clinically important finding is a fall during nutritional replenishment, so serial monitoring rather than a single measurement is required.
Reduced
Hypophosphataemia arises from three mechanisms that should be distinguished: transcellular shift (refeeding, insulin and glucose administration, respiratory alkalosis), renal wasting (hyperparathyroidism, Fanconi syndrome, FGF23-mediated disorders, diuretics), and reduced intake or absorption (malnutrition, alcohol dependence, phosphate binders, malabsorption). Severe hypophosphataemia, generally below 1.0 mg/dL, can cause muscle weakness, respiratory failure, rhabdomyolysis, haemolysis, and cardiac dysfunction, and requires prompt correction.
Note: Serum phosphorus samples only the extracellular fraction and correlates poorly with total body stores, so a normal value does not exclude depletion. Levels shift acutely with insulin, glucose, and pH independent of body content, and haemolysis or delayed separation falsely elevates results. Reference intervals are markedly higher in children and adolescents, and diurnal variation means collection timing affects comparability. Phosphorus is interpreted alongside calcium, parathyroid hormone, 25-hydroxyvitamin D, magnesium, and renal function rather than alone.
Frequently asked questions
It measures serum inorganic phosphate, the extracellular fraction of the body's principal intracellular anion. Phosphate is essential to ATP, nucleic acids, cell membranes, and bone mineralisation, and is regulated by FGF23, parathyroid hormone, and calcitriol.
How to access the Phosphorus test
The Phosphorus reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: July 16, 2026
Last reviewed: July 16, 2026
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder. Kidney Int Suppl. (2017)
- Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol. (2006)
- Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. (2008)
- Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. (2012)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
vitamins minerals
Calcium
The calcium test measures total serum calcium, the sum of protein-bound, complexed, and ionised fractions. Because roughly 40 per cent is albumin-bound, total calcium must be corrected for albumin or complemented with ionised calcium when equivocal.
vitamins minerals
Magnesium
The serum magnesium test measures circulating magnesium, the standard index of magnesium status and an essential cofactor in neuromuscular, cardiac, and metabolic function. It detects hypomagnesaemia and hypermagnesaemia and investigates refractory hypokalaemia and hypocalcaemia, which often fail to correct until magnesium is repleted.
metabolic diabetes
CMP
The Comprehensive Metabolic Panel measures 14 serum analytes surveying renal function (BUN, creatinine, eGFR), electrolytes and acid–base balance (sodium, potassium, chloride, CO₂), glucose, calcium, hepatic enzymes (AST, ALT, ALP, bilirubin), and proteins (total protein, albumin, globulin).